Clinical Research Core
Clinical Research Core
批准号:
10438753
负责人:
Robert Hal Scofield
金额:
$62.67万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2023-08-15
关键词:
AddressAdoptedAmericanAmerican IndiansArthritisAutoimmune DiseasesAutoimmunityAwardBackBloodCardiovascular DiseasesCertificationCherokee IndianChronicCitiesClinicalClinical DataClinical ResearchClinical TrialsClinical Trials Data Monitoring CommitteesCollaborationsCollectionCommunitiesContract ServicesContractsDataDegenerative polyarthritisDiabetes MellitusDoctor of PhilosophyEnsureEvaluationFundingGrantGrowthHealthHealthcareHumanHuman ResourcesHuman Subject ResearchIndividualInfrastructureInstitutesInstitutionInstitutional Review BoardsK-Series Research Career ProgramsLife ExpectancyLocationMalignant NeoplasmsMediationMedicalMedical centerMissionObesityOklahomaParticipantPathologistPatient RecruitmentsPatientsPediatricsPhasePlayPopulationProcessProtocols documentationPublicationsRegistriesReproducibilityResearchResearch PersonnelResearch Project GrantsResourcesReview CommitteeRoleRunningRuralSamplingSampling StudiesSiteSystemTranslatingTranslational ResearchTribesUnderrepresented MinorityUnited States Department of Veterans AffairsUnited States Indian Health ServiceWorkbasebiobankcareercohortcollegecost effectivedissemination researchhealthy aginghuman subjectimplementation researchimprovedinnovationmemberminority communitiesnovelobesity in childrenpopulation healthprogram disseminationprogramsrecruitrepositoryresearch facilityresearch studysample collectionsuccesstranslational research programtribal communityvolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Although some improvement has been seen between initiation of the Oklahoma Shared Clinical and
Translational Resources (OSCTR) and today (moving from 49th to 46th in rankings), Oklahoma is consistently in
or near the bottom 10% of states for the overall health of its population. The residents of the state
disproportionately suffer from chronic health problems, such as obesity, diabetes, cardiovascular disease, and
arthritis/autoimmunity. Oklahomans have a life-expectancy which is 3 years shorter than the average US
citizen and American Indians have a life-expectancy which is 7.3 years shorter than other groups within the
US. With high percentages of rural (38%) and tribal (9%) populations, Oklahoma has unique challenges and
opportunities to implement clinical and translational research (CTR) projects and dissemination and
implementation research to improve health and health care. The Clinical Resources (CR) Core of the OSCTR
has built a centralized system to support human subjects research in the state that has prioritized its focus on
these issues. The Core provides clinical research facilities and a CAP-certified Biorepository that has allowed
the OSCTR to adopt or establish registries, repositories, and cohorts to assist investigators to obtain and utilize
high-quality samples to support their research efforts. This effort has allowed the Core to provide more than
95,000 clinical samples and more than 1.6 million data fields in the first four years of the award. This support
has launched the careers of multiple CTR investigators, including researchers that are members of the under-
represented minority communities in the state. The CR Core will continue to provide this invaluable access to
sample collections while supporting the establishment of new repositories focusing on the health issues of
greatest concerns to our populations, including cancer, diabetes and osteoarthritis. The CR core is also
expanding the capabilities of its Clinical Research Units by new innovative partnerships with the Oklahoma
Blood Institute and Oklahoma City Veterans Affairs Medical Center. This will enhance the overall opportunities
of our CTR investigators to recruit participants into research studies as well as provide new capabilities to
translate research findings and effect population health through partners that interact with a large number of
previously unreached Oklahoma residents. Through the CR Core, the OSCTR is establishing a formal
Regulatory Assistance Unit to provide a centralized location for OSCTR Investigators to seek assistance with
institutional IRB applications, protocols, data safety monitoring boards and other regulatory requirements. This
Unit will work with the Administrative Core to make access to resources and information more accessible to
investigators, clinicians, clinical research staff and participants through the new Gateway to Oklahoma portal.
This unit will work closely with the OSCTR Tribal Engagement Unit to help investigators to work with the Indian
Health Service and tribal IRBs ensure the protection of both individual human subjects and tribal community
populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sjogren's Syndrome Pathogenic Autoantibodies
-
批准号:10854472
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2023
-
负责人:Robert Hal Scofield
-
依托单位:
Autoimmunity in Post-Traumatic Stress Disorder
-
批准号:9892288
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Robert Hal Scofield
-
依托单位:
Autoimmunity in Post-Traumatic Stress Disorder
-
批准号:10427168
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Robert Hal Scofield
-
依托单位:
Autoimmunity in Post-Traumatic Stress Disorder
-
批准号:10704565
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Robert Hal Scofield
-
依托单位:
Sjogren's Syndrome Pathogenic Autoantibodies
-
批准号:10450830
-
项目类别:
-
资助金额:$29.03万
-
财政年份:2019
-
负责人:Robert Hal Scofield
-
依托单位:
ShEEP Request for Peggy Sue by Bio-Techne
-
批准号:9906453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Robert Hal Scofield
-
依托单位:
Sjogren's Syndrome Pathogenic Autoantibodies
-
批准号:10213695
-
项目类别:
-
资助金额:$29.04万
-
财政年份:2019
-
负责人:Robert Hal Scofield
-
依托单位:
Mitochondrial dysfunction, metabolic syndrome and oxidative damage in Sjogren's Syndrome
-
批准号:9387723
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2017
-
负责人:Robert Hal Scofield
-
依托单位:
Clinical Core
-
批准号:8712123
-
项目类别:
-
资助金额:$30.27万
-
财政年份:2014
-
负责人:Robert Hal Scofield
-
依托单位:
Clinical Research Core
-
批准号:10218194
-
项目类别:
-
资助金额:$61.79万
-
财政年份:2013
-
负责人:Robert Hal Scofield
-
依托单位:
Clinical Resources Core
-
批准号:10721316
-
项目类别:
-
资助金额:$61.68万
-
财政年份:2013
-
负责人:Robert Hal Scofield
-
依托单位:
Sex chromosome aneuploidies in autoimmune disease
-
批准号:8333009
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert Hal Scofield
-
依托单位:
Sex chromosome aneuploidies in autoimmune disease
-
批准号:8449484
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert Hal Scofield
-
依托单位:
Sex chromosome aneuploidies in autoimmune disease
-
批准号:8795687
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert Hal Scofield
-
依托单位:
Sex chromosome aneuploidies in autoimmune disease
-
批准号:9293886
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert Hal Scofield
-
依托单位:
Sex Chromosome Aneuploidies in Autoimmune Disease
-
批准号:10347183
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert Hal Scofield
-
依托单位:
Sex chromosome aneuploidies in autoimmune disease
-
批准号:9142873
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert Hal Scofield
-
依托单位:
Sex chromosome aneuploidies in autoimmune disease
-
批准号:8698303
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert Hal Scofield
-
依托单位:
Pathogenic B Cells in Sjogren's Syndrome
-
批准号:8102494
-
项目类别:
-
资助金额:$41.78万
-
财政年份:2011
-
负责人:Robert Hal Scofield
-
依托单位:
INSULIN RESISTANCE AND GLUCOCORTICOIDS
-
批准号:7305092
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2007
-
负责人:Robert Hal Scofield
-
依托单位:
海外基金